Celyad Sa Ads (NQ: CYAD )

7.550 USD +0.040 (+0.53%)

Streaming Delayed Price Updated: 4:26 AM EDT, Oct 28, 2020 Add to My Watchlist

Price and Volume

Volume	300
Open	7.510
Bid (Size)	7.440 (5)
Ask (Size)	7.690 (10)
Prev. Close	7.510
Today's Range	7.510 - 7.550
52wk Range	4.100 - 13.01
Shares Outstanding	11,373,844
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Celyad Oncology Announces Clinical Trial Collaboration to Evaluate CYAD-101 with KEYTRUDA® (pembrolizumab) in Patients with Microsatellite Stable mCRC

September 29, 2020

Celyad Oncology to Participate in a Fireside Chat at the 7th Annual Jefferies Cell Therapy Summit

September 23, 2020

Performance

YTD	-32.89%	-32.89%
1 Month	-18.77%	-18.77%
3 Month	-27.40%	-27.40%
6 Month	-12.72%	-12.72%
1 Year	-12.92%	-12.92%

More News

Celyad Oncology to Host Virtual Research & Development Webinar on September 29

September 22, 2020

Celyad Oncology Establishes At-the-Market Facility

September 14, 2020

Celyad Oncology Announces September 2020 Conference Schedule

August 26, 2020

Celyad Oncology Reports Half Year 2020 Financial Results and Second Quarter Business Highlights

August 06, 2020

Celyad Oncology to Announce First Half 2020 Financial Results and Host Conference Call

August 03, 2020

Celyad Oncology Announces FDA Clearance of IND Application for CYAD-211, First shRNA-based, Non-Gene Edited Allogeneic CAR T Therapy

July 14, 2020

Celyad Rebrands as Celyad Oncology

June 10, 2020

The Daily Biotech Pulse: FDA Nod For Pfizer, Sorrento's COVID-19 Antibody Animal Data, Orphazyme's Wall Street Debut

September 29, 2020

55 Biggest Movers From Yesterday

July 15, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.